BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8902066)

  • 1. Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro susceptibility.
    Phillips P; Zemcov J; Mahmood W; Montaner JS; Craib K; Clarke AM
    AIDS; 1996 Oct; 10(12):1369-76. PubMed ID: 8902066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
    Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.
    Skiest DJ; Vazquez JA; Anstead GM; Graybill JR; Reynes J; Ward D; Hare R; Boparai N; Isaacs R
    Clin Infect Dis; 2007 Feb; 44(4):607-14. PubMed ID: 17243069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
    Tumbarello M; Caldarola G; Tacconelli E; Morace G; Posteraro B; Cauda R; Ortona L
    J Antimicrob Chemother; 1996 Oct; 38(4):691-9. PubMed ID: 8937963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of fluconazole and itraconazole in the treatment of oral candidiasis in HIV patients.
    Menon T; Umamaheswari K; Kumarasamy N; Solomon S; Thyagarajan SP
    Acta Trop; 2001 Oct; 80(2):151-4. PubMed ID: 11600094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients.
    Jandourek A; Vaishampayan JK; Vazquez JA
    AIDS; 1998 Jun; 12(9):1033-7. PubMed ID: 9662200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients.
    Graybill JR; Vazquez J; Darouiche RO; Morhart R; Greenspan D; Tuazon C; Wheat LJ; Carey J; Leviton I; Hewitt RG; MacGregor RR; Valenti W; Restrepo M; Moskovitz BL
    Am J Med; 1998 Jan; 104(1):33-9. PubMed ID: 9528717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review.
    White A; Goetz MB
    Clin Infect Dis; 1994 Oct; 19(4):687-92. PubMed ID: 7803633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS.
    Phillips P; De Beule K; Frechette G; Tchamouroff S; Vandercam B; Weitner L; Hoepelman A; Stingl G; Clotet B
    Clin Infect Dis; 1998 Jun; 26(6):1368-73. PubMed ID: 9636865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295.
    Fichtenbaum CJ; Zackin R; Rajicic N; Powderly WG; Wheat LJ; Zingman BS
    AIDS; 2000 May; 14(7):845-52. PubMed ID: 10839593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations.
    Pelletier R; Peter J; Antin C; Gonzalez C; Wood L; Walsh TJ
    J Clin Microbiol; 2000 Apr; 38(4):1563-8. PubMed ID: 10747144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between antifungal susceptibility testing of Candida isolates from patients with HIV infection and clinical results after treatment with fluconazole.
    Ruhnke M; Eigler A; Engelmann E; Geiseler B; Trautmann M
    Infection; 1994; 22(2):132-6. PubMed ID: 8070927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis].
    Eichel M; Just-Nübling G; Helm EB; Stille W
    Mycoses; 1996; 39 Suppl 1():102-6. PubMed ID: 8767280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Itraconazole solution: summary of pharmacokinetic features and review of activity in the treatment of fluconazole-resistant oral candidosis in HIV-infected persons.
    Koks CH; Meenhorst PL; Bult A; Beijnen JH
    Pharmacol Res; 2002 Aug; 46(2):195-201. PubMed ID: 12220961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Candida albicans isolates with reduced susceptibility to fluconazole in Swedish HIV-infected patients.
    Chryssanthou E; Torssander J; Petrini B
    Scand J Infect Dis; 1995; 27(4):391-5. PubMed ID: 8658076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS].
    Tebbe B; Boyvat A; Geilen CC; Wölfer LU; Seibold M; Orfanos CE
    Hautarzt; 1996 Feb; 47(2):136-9. PubMed ID: 8868459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of single-dose fluconazole compared with a 7-day regimen of itraconazole in the treatment of AIDS-related oropharyngeal candidiasis.
    De Wit S; O'Doherty E; De Vroey C; Clumeck N
    J Int Med Res; 1998; 26(3):159-70. PubMed ID: 9718471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
    Barchiesi F; Arzeni D; Del Prete MS; Sinicco A; Falconi Di Francesco L; Pasticci MB; Lamura L; Nuzzo MM; Burzacchini F; Coppola S; Chiodo F; Scalise G
    J Antimicrob Chemother; 1998 May; 41(5):541-8. PubMed ID: 9630407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unresponsive HIV-related oro-oesophageal candidosis--an evaluation of two new in-vitro azole susceptibility tests.
    Cartledge JD; Midgley J; Petrou M; Shanson D; Gazzard BG
    J Antimicrob Chemother; 1997 Oct; 40(4):517-23. PubMed ID: 9372421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.